Bioactive NHC-transition metal complexes have shown promise
as
anti-cancer agents, but their potential use as radiosensitizers has
been neglected so far. We disclose here a new series of bimetallic
platinum(II) complexes displaying NHC-type bridging ligands, (bis-NHC)[trans-Pt(RNH2)I2]2, that
have been synthesized via a simple, two-step procedure. They display
cytotoxicity in the micromolar range on cancerous cell lines, accumulate
in cells, and bind to genomic DNA, by inducing DNA damages. Notably,
these bimetallic complexes demonstrate significant radiosensitizing
effects on both ovarian cells A2780 and nonsmall lung carcinoma cells
H1299. Further investigations revealed that bimetallic species make
irradiation-induced DNA damages more persistent by inhibiting repair
mechanisms. Indeed, a higher and persistent accumulation of both γ-H2AX
and 53BP1 foci post-irradiation was detected, in the presence of the
NHC-Pt complexes. Overall, we provide the first in vitro evidence
for the radiosensitizing properties of NHC-platinum complexes, which
suggests their potential use in combined chemo-radio therapy protocols.